Uniphar (LON:UPR) Reaches New 12-Month High – Should You Buy?

Shares of Uniphar plc (LON:UPRGet Free Report) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as GBX 368 and last traded at GBX 368, with a volume of 33264 shares trading hands. The stock had previously closed at GBX 348.

Uniphar Stock Down 1.4%

The business’s 50 day moving average is GBX 322.90 and its 200 day moving average is GBX 330.79. The company has a quick ratio of 0.60, a current ratio of 0.90 and a debt-to-equity ratio of 119.48. The company has a market cap of £916.30 million, a P/E ratio of 14.41 and a beta of 0.75.

Insider Activity at Uniphar

In related news, insider Gerard Rabbette sold 43,355 shares of the company’s stock in a transaction on Wednesday, December 10th. The stock was sold at an average price of GBX 362, for a total transaction of £156,945.10. Insiders own 7.65% of the company’s stock.

About Uniphar

(Get Free Report)

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.

See Also

Receive News & Ratings for Uniphar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uniphar and related companies with MarketBeat.com's FREE daily email newsletter.